Bronstein, Gewirtz & Grossman, LLC Investigates Potential Claims against Acadia Healthcare
Bronstein, Gewirtz & Grossman, LLC, a leading national securities fraud law firm, is investigating potential claims on behalf of investors of Acadia Healthcare Company, Inc. (Acadia Healthcare or the Company) following a recent securities class action lawsuit filed against the company. The investigation concerns whether Acadia Healthcare and certain of its officers and directors violated the federal securities laws.
Background
Acadia Healthcare is a provider of inpatient behavioral healthcare services. The Company operates through two segments: Behavioral Health and Hospital Operations. Acadia Healthcare’s Behavioral Health segment includes inpatient psychiatric hospitals, outpatient clinics, and residential treatment centers. The Hospital Operations segment includes general acute care hospitals and specialized hospitals. Acadia Healthcare’s common stock is traded on the NASDAQ under the symbol “ACHC.”
Investigation Details
The investigation focuses on whether Acadia Healthcare and its executives made false and/or misleading statements and/or failed to disclose material information to investors. Specifically, the investigation concerns whether the Company and its executives made false and/or misleading statements and/or failed to disclose: (i) the extent of the Company’s exposure to Medicaid and Medicare reimbursement risks; (ii) the impact of the Company’s revenue cycle issues on its financial results; and (iii) the Company’s compliance with regulations related to its billing and reimbursement practices.
Class Action Lawsuit
On February 27, 2023, a class action lawsuit was filed against Acadia Healthcare in the United States District Court for the Middle District of Tennessee. The complaint alleges that Acadia Healthcare and its executives violated the Securities Exchange Act of 1934 by making false and/or misleading statements and/or failing to disclose material information to investors.
Effect on Individual Investors
If you purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, you may be able to assist in the investigation and potentially recover your losses. The investigation seeks to recover damages for Acadia Healthcare investors who have suffered financial losses due to the alleged securities laws violations.
Effect on the World
The investigation and class action lawsuit against Acadia Healthcare are significant because they highlight the importance of transparency and accuracy in financial reporting. The healthcare industry is a critical sector of the economy, and investors rely on accurate information to make informed decisions. The failure to provide such information can have serious consequences, not only for investors but also for the healthcare providers and the patients they serve.
Conclusion
Bronstein, Gewirtz & Grossman, LLC is dedicated to ensuring that investors receive compensation for their losses. The investigation into potential claims against Acadia Healthcare is ongoing, and the firm encourages investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, to visit bgandg.com/ACHC for more information and to assist in the investigation. If you have any information, please contact Peretz Bronstein or his law clerk, Yael Nathanson, at 212-697-6484 or [email protected].
- Acadia Healthcare Company, Inc. (ACHC)
- Bronstein, Gewirtz & Grossman, LLC
- Securities fraud investigation
- Potential claims against Acadia Healthcare
- False and/or misleading statements
- Failure to disclose material information
- Securities Exchange Act of 1934
- Class action lawsuit
- Transparency and accuracy in financial reporting
- Healthcare industry
